While we observed an enrichment of such pathway in our recurring primary tumor set, there was no significant increased frequency in PIK3CA or AKT1 mutations when compared to frequencies reported in the TCGA sample set (PIK3CA p = 0.060; AKT1 no mutations detected). This evidence concerns the gene AKT1 and neoplasm.